Christopher R. Anzalone
Chairman, CEO & PresidentDr. Christopher R. Anzalone, also known as Chris, Ph.D., has been the Chief Executive Officer and President at Arrowhead Pharmaceuticals, Inc. since December 1, 2007 and serves as its Chairman. He serves as Chief Executive Officer of Calando Pharmaceuticals, Inc. Dr. Anzalone serves as a Director at Unidym, Inc. Dr. Anzalone was the Founder and CEO of Benet Group, LLC. He has a wealth of experience in nanotechnology, biotechnology, company-building, biomedical research, investment banking, financial services and venture capital. Dr. Anzalone is also the founding Chief Executive Officer of Leonardo Biosystems. Prior to his tenure at the Benet Group, from 1999 until 2003, he was a partner at Galway Partners, LLC, where he was responsible for sourcing, structuring and building new business ventures. He was the founding Chief Executive Officer of NanoInk, Inc. He also served as an acting Chief Executive Officer and Chairman for few years at NanoInk. He serves as Chairman and Director of Calando Pharmaceuticals, Inc. He has been a Director of Arrowhead Pharmaceuticals, Inc. since December 1, 2007. He served as a Director of NanoInk, Inc. Before joining Galway, Dr. Anzalone was a National Institutes of Health Fellow at the Smithsonian Institution's Conservation and Research Center Division of the National Zoological Park specializing in embryology and altered germ cell DNA-protein interactions. His research at the Smithsonian and prior to that at the University of California Los Angeles was funded for few years by the NIH. He was an active scientist with publications in the areas of Molecular Biology, Endocrine Physiology, Reproductive Biology and Conservation Biology. Dr. Anzalone is the author of numerous peer-reviewed research publications and has served as a reviewer for international scientific journals. He is the recipient of several professional and academic honors and has been a featured speaker at conferences, symposia and research institutions. Dr. Anzalone holds a Ph.D. and an M.A. in Biology from UCLA and a B.A. Government from Lawrence University. He was the founding Chief Executive Officer of Nanotope Inc.
Positions
- Company NameArrowhead Pharmaceuticals, Inc.Stock CodeARWRPositionChairman, CEO & PresidentColleagues
- DJDaniel J. ApelChief Financial Officer
- POPatrick O'BrienCOO & Secretary
- JCJames C. HamiltonChief Medical Officer and Head of R&D
- MMMark M. DavisFounder and Founder & Director of Insert Therapeutics Inc & Calando
- MSMichael Steven PerryIndependent Director
- RGRobert G. GishChairman of Hepatitis B Clinical Advisory Board
- WDWilliam D. WaddillIndependent Lead Director
